About this trial

The goal of this clinical trial is to develop and test an app designed to reduce suicide risk and improve emotional well-being in adolescents. The study will test if the app's daily check ins and recommended mood boosting skills will improve the adolescent's overall mood and suicidality. The main question it aims to answer is:

• Is the app practical and acceptable to use daily?

In the study, adolescents will:

* Participate in a focus group with other adolescents and provide feedback on the app itself (design, ease of use, etc.). * Complete surveys and assessments on their mood, thoughts, and experiences. * Complete assessments about their app experience.

In the study, the legal guardian of the adolescent will:

* Participate in a focus group with other adolescents and provide feedback on the app itself (design, ease of use, etc.). * Complete assessments about their app experience.

Eligibility criteria

Qualifiers

Aged 13-17 years old

Recent suicidal ideation

Access to a smartphone device

Residing in the Philadelphia metropolitan area

Disqualifiers

Psychotic disorder, including schizophrenia, schizoaffective disorder, or psychotic disorder not otherwise specified, with a past year psychotic episode prior to baseline

Bipolar disorder I diagnosis, with a past year manic episode prior to baseline

Imminent suicide risk (e.g., active suicidal ideation with a specific plan and intent)

Trial design

Treatments tested in this trial

  • Suicide prevention treatment

Treatment groups

No treatment groups listed

Locations

1
University of Pennsylvania19104, PhiladelphiaPennsylvania, United States

Sponsors and collaborators

University of Pennsylvania

Lead sponsor